In a year affected by the coronavirus, cannabis stocks haven’t escaped market volatility, and this has impacted the performance of exchange-traded funds (ETFs) in the public space.

ETFs offer a basket of stocks as an investment vehicle for those who may be hesitant to pick individual names. ETF companies have made their case in cannabis by promoting the reassurance of having broad exposure in what is still a fairly new investment market.

Despite their relative stability in a volatile sector, cannabis ETFs still see periods of change depending on the state of the industry. Some have added active management as a way to bolster themselves from the flippant state of cannabis investments, but it’s tough to stay ahead in a down market.

Here the Investing News Network (INN) takes a closer look at how the most relevant cannabis ETFs have performed in 2020 so far. The following Canadian funds all had net assets of over US$10 million at the time of publication; year-to-date percentage changes were calculated up until July 31, 2020.

1. Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ)

Year-to-date percentage change: -17.27 percent

The one that started it all in Canada, HMMJ is still an outlet for the biggest cannabis names in the sector.

The largest holdings in the fund are Canopy Growth (NYSE:CGC,TSX:WEED), GW Pharmaceuticals (NASDAQ:GWPH) and Cronos Group (NASDAQ:CRON,TSX:CRON).

Over a year-to-date time period, the index that HMMJ tracks has decreased significantly as cannabis continues to take its lumps. The fund has gone down in value 17.27 percent for a price of C$7.09.

“Whenever you’re dealing with an early stage industry, like the global cannabis market, you’re going to have a high degree of failure, and what you’re hoping to do is capture in some way, shape or form the successful companies that are going to be the leaders of the sector,” Mark Noble, senior vice president of ETF strategy with Horizons ETFs, previously told INN.

2. ETFMG Alternative Harvest ETF (ARCA:MJ)

Year-to-date percentage change: -23.43 percent

MJ abides by the rules for cannabis in the US, meaning no active US cannabis companies will be included in the ETF until some of kind of reform is seen in the country.

“Even in those states in which the use of marijuana has been legalized, its possession and use remains a violation of federal law,” the fund’s documents indicate.

This fund utilizes the Prime Alternative Harvest Index as its tracking measurement. The largest names based on weight in MJ are the same as for HMMJ: GW Pharmaceuticals, Cronos and Canopy.

So far this year, the fund has decreased in value by 23.43 percent. The losses were extended by a sharp decline around February and March as the coronavirus pandemic began to really impact the performance of global markets.

At the end of July, the ETF ran at a value of US$12.94 per share.

3. Amplify Seymour Cannabis ETF (ARCA:CNBS)

Year-to-date percentage change: -9.91 percent

The launch of this ETF attracted a lot of attention based on the involvement of Tim Seymour, CIO of Seymour Asset Management and co-host of CNBC’s Fast Money. “An active approach is the only way to invest in a sector like this that’s changing by the day,” Seymour previously said.

The fund itself touts the advantage of having Seymour contribute to the management and direction of the ETF, counting his investment expertise and personal involvement in the sector as elements that may entice investors to take a closer look.

Despite the challenges this year, CNBS has seen a marginally less intense loss than other ETF players. Over a year-to-date period, it has decreased in value by 9.91 percent, resulting in a price of US$11.91.

CNBS has the same top holdings as the previous ETFs listed, which highlights the similarities in stocks seen in cannabis funds at the moment.

4. AdvisorShares Pure Cannabis ETF (ARCA:YOLO)

Year-to-date percentage change: -3.03 percent

This fund has the distinction of launching as one of the first actively managed ETFs in the cannabis space. Having an active manager in charge of the fund means there is a market observer following its day-to-day performance and making any necessary or possible adjustments.

Dan Ahrens, managing director with AdvisorShares, acts as the manager of this fund, which has a 0.6 percent fee. The top holdings for YOLO are Village Farms International (NASDAQ:VFF,TSX:VFF), Innovative Industrial Properties (NYSE:IIPR) and GW Pharmaceuticals.

This fund has also had a difficult year, but its decline has been only 3.03 percent — and in fact, it is inching closer to its highest price point of the year. At the end of July, the fund was priced at US$11.54.

This ETF offers investors a chance at exposure into names in the cannabis universe across the US and Canada, primordially.

5. The Cannabis ETF (ARCA:THCX)

Year-to-date percentage change: -18.32 percent

THCX was part of the rush of new cannabis ETFs launched in 2019. This fund also offers exposure to global cannabis corporations and stays away from any company touching the plant in the US.

This fund’s top holdings are an all-Canadian company lineup of Cronos, Aphria (NYSE:APHA,TSX:APHA) and Canopy Growth.

As far its performance so far in 2020, the fund has dropped in value significantly by 18.32 percent, and at the end of July it held a price of US$10.21.

6. Cambria Cannabis ETF (CBOE:TOKE)

Year-to-date percentage change: -16.38 percent

ETF provider Cambria Investment Management launched this fund as a way to gain entry into the cannabis investment arena, and invests in between 20 and 50 of the biggest companies available.

TOKE is an actively managed fund led by Mebane T. Faber, which costs investors a 0.59 percent management fee. Its top holdings are GW Pharmaceuticals, Aphria and Scotts Miracle-Gro (NYSE:SMG).

TOKE has struggled in 2020, and the fund had dropped 16.38 percent in value by the end of July, ending with a price of US$12.71. As of June 30, TOKE had dropped by 48.18 percent since its original launch date.


Want more details? Check out these articles for more INNdepth coverage:

Want an overview of investing in cannabis stocks? Check out Investing in the Cannabis Industry.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less